Leishmania major: Activity of tamoxifen against experimental cutaneous leishmaniasis

Experimental Parasitology

Volumn 128, Issue 4, 2011, Pages 382-390

  Eissa, Maha M ^a   Amer, Eglal I ^a   El Sawy, Shefaa M F ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Cutaneous leishmaniasis; Experimental; In vivo; Leishmania major; Tamoxifen; Testis

Indexed keywords

TAMOXIFEN CITRATE;

AMASTIGOTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; IN VIVO STUDY; LEISHMANIA MAJOR; MALE; MALE FERTILITY; MOUSE; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; SCROTAL SWELLING; SKIN LEISHMANIASIS; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT DURATION;

ANIMALS; ANTIPROTOZOAL AGENTS; DISEASE MODELS, ANIMAL; FEMALE; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MALE; MICE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SKIN; TAMOXIFEN; TESTIS;

LEISHMANIA MAJOR; MUS; PROTOZOA;

EID: 79960561011     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2011.05.009     Document Type: Article

References (42)

1. Altan N., Chen Y., Schindler M., et al. Defective acidification in human breast tumor cells and implications for chemotherapy. Journal of Experimental Medicine 1998, 187:1583-1598.
2. Barret M.P., Mott-ram J.C., Commbs G.H. Recent advances in identifying and validating drug targets in Trypanosomes and Leishmanias. Trends in Microbiology 1999, 7:82-88.
3. Beggs W.H. Drug protonation and pH in relation to the lethal action of tamoxifen on Candida albicans. Journal of Antimicrobial Chemotherapy 1996, 37:841-842.
4. Blum J., Desjeux P., Schwartz E., Beck B., Hartz C. Treatment of cutaneous leishmaniasis among travellers. Journal of Antimicrobial Chemotherapy 2004, 53:158-166.
5. Croft S.L., Coombs G.H. Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs. Trends in Parasitology 2003, 19:502-508.
6. Chulay J.D., Bryceson A.M. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. The American Journal of Tropical Medicine and Hygiene 1983, 32:475-479.
7. Damber J.E., Abramsson L., Duchek A. Tamoxifen treatment of idiopathic oligozoospermia: effect on hCG-induced testicular steroidogenesis and semen variables. Scandinavian Journal of Urology and Nephrology 1989, 23:241-246.
8. Drutz D.J., Huppert M., Sun S.H., et al. Human sex hormones stimulate the growth and maturation of Coccidioides immitis. Infection and Immunity 1981, 32:897-907.
9. D'Souza U.J. Tamoxifen induced multinucleated cells (symplasts) and distortion of seminiferous tubules in rat testis. Asian Journal of Andrology 2003, 5:217-220.
10. D′Souza U.J. Effect of tamoxifen on spermatogenesis and tubular morphology in rats. Asian Journal of Andrology 2004, 6:223-226.
11. Escobar P., Matus S., Marques C., Croft S.L. Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), Et-18-och3 (eldefosine) and amphottericin B. Acta Tropica 2002, 81:151-157.
12. Garnier T., Mäntylä A., Järvinen T., Lawrence J., Brown M., et al. In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs. Journal of Antimicrobial Chemotherapy 2007, 60:802-810.
13. Gopalkrishnan K., Gill-Sharma M.K., Balasinor N., Padwal V., D'Souza S., Parte P., et al. Tamoxifen-induced light and electron microscopic changes in rat testicular morphology and serum hormonal profile of reproductive hormones. Contraception 1998, 57:261-269.
14. Hayat M.A. Principles and techniques of EM: Biological application 1981, Union New Jersey University Pock Press. second ed.
15. Jordan V.C. Tamoxifen: a most unlikely pioneering medicine. Nature Reviews Drug Discovery 2003, 2:205-213.
16. Kisanga E.R., Gjerde J., Guerrieri-Gonzaga A., et al. Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial. Clinical Cancer Research 2004, 10:2336-2343.
17. Krause W., Holland-Moritz H., Schramm P. Treatment of idiopathic oligozoospermia with tamoxifen- a randomized controlled study. International Journal of Andrology 1992, 15:14-18.
18. Lien E.A., Solheim E., Ueland P.M. Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment. Cancer Research 1991, 51:4837-4844.
19. Mandlekar S., Kong A.N. Mechanisms of tamoxifen-induced apoptosis. Apoptosis 2001, 6:469-477.
20. McCartry-Burke C., Bates P.A., Dwyer D.M. L.donovani: use of two different commercially available chemically defined media for the continuous in vitro cultivation of promastigotes. Experimental Parasitology 1991, 73:385-387.
21. Messins I.E., Nillius S.J. Comparison between tamoxifen and clomiphene for induction of ovulation. Acta. Obstetrica et gynecologica Scandinavica 1982, 61:377-379.
22. Miguel D.C., Yokoyama-Yasunaka J.K., Andreoli W.K., Mortara R.A., Uliana S.R. Tamoxifen is effective against leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes. Journal of Antimicrobial Chemotherapy 2007, 60:526-534.
23. Miguel, D.C., Yokoyama-Yasunaka, J.K., Uliana, S.R. (2008). Tamoxifen is effective in the treatment of Leishmania amazonensis infections in mice. PLoS Neglected Tropical Diseases. 11;2(6):e249.
24. Miguel D.C., Zauli-Nascimento R.C., Yokoyama-Yasunaka J.K., Katz S., Barbiéri C.L., Uliana S.R. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections. Journal of Antimicrobial Chemotherapy 2009, 63:365-368.
25. Motrich R.D., Ponce A.A., Rivero V.E. Effect of tamoxifen treatment on the semen quality and fertility of the male rat. Fertility and Sterility 2007, 88:452-461.
26. Murray H.W. Progress in the treatment of a neglected infectious disease: visceral leishmaniasis. Expert Review of Anti- Infective Therapy 2004, 2:279-292.
27. Negm, A.Y, (1994). Experimental study on cutaneous leishmaniasis, MD Thesis, Faculty of Medicine. Alexandria University, Egypt.
28. Nistal M., Paniagua R. Testicular and epididymal pathology 1984, Stutgart, New York, Georg Thieme, Verlag, 14-52.
29. Padmalatha Rai S., Vijayalaxmi K.K. Tamoxifen citrate induced sperm shape abnormalities in the in vivo mouse. Mutation Research 2001, 492:1-6.
30. Pontiggia O., Rodriguez V., Fabris V., et al. Establishment of an in vitro oestrogen-dependent mouse mammary tumor model: a new tool to understand oestrogen responsiveness and development of tamoxifen resistance in the context of stromal-epithelial interactions. Breast Cancer Research and Treatment 2009, 116:247-255.
31. Soto J., Arana B.A., Toledo J., Rizzo N., Vega J.C., Diaz A., et al. Miltefosine for new world cutaneous leishmaniasis. Clinical Infectious Diseases 2004, 38:1266-1272.
32. Soto J., Rea J., Balderrama M., Toledo J., Soto P., Valda L., Berman J.D. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis. American Journal of Tropical Medicine and Hygiene 2008, 78:210-216.
33. Sundar S., Jha T.K., Thakur C.P., Engel J., Sindermann H., et al. Oral miltefosine for Indian visceral leishmaniasis. New England Journal of Medicine 2002, 347:1739-1746.
34. Trouiller P., Olliaro P., Torreele E., Orbinski J., Laing R., et al. Drug development for neglected diseases: a deficient market and a public health policy failure. Lancet 2002, 359:2188-2194.
35. Vandekerckhove, P., Lilford, R., Vail, A., Hughes, E. (2000). Clomiphene or tamoxifen for idiopathic oligo/asthenospermia Cochrane. Data base Systemic Review. (2), CD000151.
36. Vergel C., Palacios R., Cadena H., et al. Evidence for Leishmania (Viannia) parasites in the skin and blood of patients before and after treatment. Journal of Infectious Diseases 2006, 194:503-511.
37. Vogel V.G., Costantino J.P., Wickerham D.L., et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. Journal of the American Medical Association 2006, 295:2727-2741.
38. Wiseman H., Cannon M., Arnstein H.R. The protective effect of ascorbate on the inhibition of growth, RNA and protein synthesis by tamoxifen in yeast is time dependent. Biochemical Society Transactions 1990, 18:1167116-1167118.
39. WHO (2001) Leishmaniasis: The diseases and its impact [online]. , (accessed 14.04.03). http://www.who.int/emc/diseases/leish/leisdis1.html.
40. WHO (2007): Special programme for Research and training in Tropical Diseases (TDR). (accessed 3.05.07). http://www.who.int/tdr/diseases/leish/.
41. Yildiz A., Guleryuz S., Ankerst D.P., et al. Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. Archives of General Psychiatry 2008, 65:255-263.
42. Youssef M.Y., Eissa M.M., Abou El-Naga I.F., El-Gowhary S.H. Dissemination of leishmania to organs of mice expermintally infected with Leishmania tropica. Journal of the Egyptian Society of Parasitology 1996, 26:719-731.